"Tbilisi State Medical University's and Ingorokva's University Clinic of High Medical Technologies" LTD
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ingorokva, Giorgi
NCT04939116 / 2021-006579-41: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Recruiting
2
100
US, RoW
ANG-3070, Placebo
Angion Biomedica Corp, Angion Biomedica Corp.
Glomerular Disease, Proteinuria
07/23
08/23
Tchokhonelidze, Irma
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Recruiting
3
429
RoW
Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp®
Genexine, Inc., PT Kalbe Genexine Biologics
Anemia of Chronic Kidney Disease
12/26
09/27
NCT04939116 / 2021-006579-41: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Recruiting
2
100
US, RoW
ANG-3070, Placebo
Angion Biomedica Corp, Angion Biomedica Corp.
Glomerular Disease, Proteinuria
07/23
08/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ingorokva, Giorgi
NCT04939116 / 2021-006579-41: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Recruiting
2
100
US, RoW
ANG-3070, Placebo
Angion Biomedica Corp, Angion Biomedica Corp.
Glomerular Disease, Proteinuria
07/23
08/23
Tchokhonelidze, Irma
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Recruiting
3
429
RoW
Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp®
Genexine, Inc., PT Kalbe Genexine Biologics
Anemia of Chronic Kidney Disease
12/26
09/27
NCT04939116 / 2021-006579-41: Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Recruiting
2
100
US, RoW
ANG-3070, Placebo
Angion Biomedica Corp, Angion Biomedica Corp.
Glomerular Disease, Proteinuria
07/23
08/23

Download Options